The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
Partial volume correction in quantitative amyloid imaging
Open accessAbstract
Amyloid imaging is a valuable tool for research and diagnosis in dementing disorders. As positron emission tomography (PET) scanners have limited spatial resolution, measured signals are distorted by partial volume effects. Various techniques have been proposed for correcting partial volume effects, but there is no consensus as to whether these techniques are necessary in amyloid imaging, and, if so, how they should be implemented. We evaluated a two-component partial volume correction technique and a regional spread function technique using both simulated and human Pittsburgh compound B (PiB) PET imaging data. Both correction techniques compensated for partial volume effects and yielded improved detection of subtle changes in PiB retention. However, the regional spread function technique was more accurate in application to simulated data. Because PiB retention estimates depend on the correction technique, standardization is necessary to compare results across groups. Partial volume correction has sometimes been avoided because it increases the sensitivity to inaccuracy in image registration and segmentation. However, our results indicate that appropriate PVC may enhance our ability to detect changes in amyloid deposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Quality control reviewed post-processing PUP output 42,43 , which includes uptake measure for FreeSurfer-based regions, was included for 1356 PET sessions.”
From OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease (2019) · cites this paper as [42]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Su et al. 42,49 has demonstrated that the RSF technique was able to improve PET quantification and achieve better sensitivity to longitudinal changes in amyloid burden.”
From OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease (2019) · cites this paper as [42]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“PET imaging analyses were performed using the PET unified pipeline 42,43 (PUP, https://github.com/ysu001/PUP) via XNAT on Dell PowerEdge 1950 servers with Intel Xeon processors running CentOS 5.5 Linux.”
From OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease (2019) · cites this paper as [42]
Experimental — accuracy not yet measuredIn the citing paper
“Both types of PET data were partial volume corrected using a regional spread function technique27,28.”
From Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study (2018) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Self-citationThe Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Self-citationGauthier, S. G., Reisberg, ., Zaudig, M., Petersen, R. C., Ritchie, K. A., Broich, K., Belleville, S., Brodaty, H., Bennett, D. A., Chertkow, H. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 4,094
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Self-citationForecasting the global burden of Alzheimer's disease
Brookmeyer, R., Johnson, E., Ziegler‐Graham, K., & Arrighi, H. M. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.04.381 · Cited by 3,370
Alzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758
Partial-Volume Effect in PET Tumor Imaging
Soret, M., Bacharach, S. L., & Buvat, I. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.035774 · Cited by 1,597
Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G., Ding, Y., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,515
Han, X., Jovicich, J., Salat, D., van der Kouwe, A., Quinn, B., Czanner, S., Busa, E., Pacheco, J., Albert, M., Killiany, R., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.02.051 · Cited by 1,508
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., HITZEMANN, R. J., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,481
Cited by
Sorted by citations
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
Schindler, S. E., Bollinger, J. G., Ovod, V., Mawuenyega, K. G., Li, Y., Gordon, B. A., Holtzman, D. M., Morris, J. C., Benzinger, T. L. S., Xiong, C., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008081 · Cited by 885
Self-citationLaMontagne, P. J., Benzinger, T. L., Morris, J. C., Keefe, S., Hornbeck, R., Xiong, C., Grant, E., Hassenstab, J., Moulder, K., Vlassenko, A. G., et al. (2019) · medRxiv · doi:10.1101/2019.12.13.19014902 · Cited by 779
“PUP accounts for these distortion correction technique is implemented using a regional spread function (RSF) based approach 42,48 .”
InfluentialSelf-citationTau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
Brier, M. R., Gordon, B., Friedrichsen, K., McCarthy, J., Stern, A., Christensen, J., Owen, C., Aldea, P., Su, Y., Hassenstab, J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2362 · Cited by 734
Self-citationthe Dominantly Inherited Alzheimer Network, Barthélemy, N. R., Li, Y., Joseph-Mathurin, N., Gordon, B. A., Hassenstab, J., Benzinger, T. L. S., Buckles, V., Fagan, A. M., Perrin, R. J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0781-z · Cited by 651
Self-citationGordon, B. A., Blazey, T. M., Su, Y., Hari-Raj, A., Dincer, A., Flores, S., Christensen, J., McDade, E., Wang, G., Xiong, C., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30028-0 · Cited by 602
Self-citationTau Kinetics in Neurons and the Human Central Nervous System
Sato, C., Barthélemy, N. R., Mawuenyega, K. G., Patterson, B. W., Gordon, B. A., Jockel-Balsarotti, J., Sullivan, M., Crisp, M. J., Kasten, T., Kirmess, K. M., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.02.015 · Cited by 586
Self-citationGut microbiome composition may be an indicator of preclinical Alzheimer’s disease
Ferreiro, A. L., Choi, J., Ryou, J., Newcomer, E. P., Thompson, R., Bollinger, R. M., Hall-Moore, C. M., Ndao, I. M., Sax, L., Benzinger, T. L. S., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo2984 · Cited by 384
Self-citationA trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
Salloway, S., Farlow, M., McDade, E., Clifford, D. B., Wang, G., Llibre-Guerra, J. J., Hitchcock, J. M., Mills, S. L., Santacruz, A. M., Aschenbrenner, A. J., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01369-8 · Cited by 359
Self-citationLa Joie, R., Ayakta, N., Seeley, W. W., Borys, E., Boxer, A. L., DeCarli, C., Doré, V., Grinberg, L. T., Huang, E., Hwang, J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.09.001 · Cited by 317
Self-citationLoss of Brain Aerobic Glycolysis in Normal Human Aging
Goyal, M. S., Vlassenko, A. G., Blazey, T. M., Su, Y., Couture, L. E., Durbin, T. J., Bateman, R. J., Benzinger, T. L.-S., Morris, J. C., & Raichle, M. E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.010 · Cited by 318
Self-citationSutphen, C. L., Jasielec, M. S., Shah, A. R., Macy, E. M., Xiong, C., Vlassenko, A. G., Benzinger, T. L. S., Stoops, E., Vanderstichele, H., Brix, B., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1285 · Cited by 301
Self-citationWang, L. Y., Benzinger, T. L. S., Su, Y., Christensen, J. J., Friedrichsen, K. A., Aldea, P., McConathy, J., Cairns, N. J., Fagan, A. M., Morris, J. C., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2078 · Cited by 301
Self-citationInfluence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease
Aschenbrenner, A. J., Gordon, B. A., Benzinger, T. L. S., Morris, J. C., & Hassenstab, J. J. (2018) · Neurology · doi:10.1212/wnl.0000000000006075 · Cited by 290
Self-citationCerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging
Schindler, S. E., Gray, J. D., Gordon, B. A., Xiong, C., Batrla‐Utermann, R., Quan, M., Wahl, S., Benzinger, T. L. S., Holtzman, D. M., Morris, J. C., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.01.013 · Cited by 284
Self-citationCerebrospinal Fluid Aβ 42/40 Corresponds Better than Aβ 42 to Amyloid PET in Alzheimer’s Disease
Lewczuk, P., Matzen, A., Blennow, K., Parnetti, L., Molinuevo, J. L., Eusebi, P., Kornhuber, J., Morris, J. C., & Fagan, A. M. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160722 · Cited by 253
Self-citationJack, C. R., Wiste, H. J., Weigand, S. D., Knopman, D. S., Mielke, M. M., Vemuri, P., Lowe, V. J., Senjem, M. L., Gunter, J. L., Reyes, D. A., et al. (2015) · Brain · doi:10.1093/brain/awv283 · Cited by 258
Ishii, M., & Iadecola, C. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.016 · Cited by 245
Quantification of amyloid PET for future clinical use: a state-of-the-art review
Pemberton, H. G., Collij, L. E., Heeman, F., Bollack, A., Shekari, M., Salvadó, G., Alves, I. L., Garcia, D. V., Battle, M., Buckley, C., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05784-y · Cited by 226
Klein, G., Delmar, P., Voyle, N., Rehal, S., Hofmann, C., Abi-Saab, D., Andjelkovic, M., Ristic, S., Wang, G., Bateman, R., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0559-z · Cited by 212
Self-citationThomas, B. A., Cuplov, V., Bousse, A., Mendes, A., Thielemans, K., Hutton, B. F., & Erlandsson, K. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/22/7975 · Cited by 197
González‐Escamilla, G., Lange, C., Teipel, S. J., Buchert, R., & Grothe, M. J. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.12.077 · Cited by 186
Gordon, B. A., Friedrichsen, K., Brier, M., Blazey, T., Su, Y., Christensen, J., Aldea, P., McConathy, J., Holtzman, D. M., Cairns, N. J., et al. (2016) · Brain · doi:10.1093/brain/aww139 · Cited by 184
Self-citationGordon, B. A., Blazey, T. M., Christensen, J., Dincer, A., Flores, S., Keefe, S., Chen, C., Su, Y., McDade, E. M., Wang, G., et al. (2019) · Brain · doi:10.1093/brain/awz019 · Cited by 180
Self-citationCSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer’s disease
Horie, K., Barthélemy, N. R., Sato, C., & Bateman, R. J. (2021) · Brain · doi:10.1093/brain/awaa373 · Cited by 180
Self-citationPersistent metabolic youth in the aging female brain
Goyal, M. S., Blazey, T., Su, Y., Couture, L. E., Durbin, T. J., Bateman, R. J., Benzinger, T. L. S., Morris, J. C., Raichle, M. E., & Vlassenko, A. G. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815917116 · Cited by 181
Self-citationAV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure
Mishra, S., Gordon, B. A., Su, Y., Christensen, J. J., Friedrichsen, K. A., Jackson, K., Hornbeck, R. C., Balota, D. A., Cairns, N. J., Morris, J. C., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.07.050 · Cited by 178
Self-citationLongitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype
Mishra, S., Blazey, T. M., Holtzman, D. M., Cruchaga, C., Su, Y., Morris, J. C., Benzinger, T. L. S., & Gordon, B. A. (2018) · Brain · doi:10.1093/brain/awy103 · Cited by 151
Self-citationBarthélemy, N. R., Saef, B., Li, Y., Gordon, B. A., He, Y., Horie, K., Stomrud, E., Salvadó, G., Janelidze, S., Sato, C., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00380-7 · Cited by 153
Self-citationDage, J. L., Wennberg, A. M. V., Airey, D. C., Hagen, C. E., Knopman, D. S., Machulda, M. M., Roberts, R. O., Jack, C. R., Petersen, R. C., & Mielke, M. M. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.001 · Cited by 145
Schindler, S. E., Karikari, T. K., Ashton, N. J., Henson, R. L., Yarasheski, K. E., West, T., Meyer, M. R., Kirmess, K. M., Li, Y., Saef, B. A., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200358 · Cited by 141
Self-citationComparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studies
Su, Y., Flores, S. E., Wang, G., Hornbeck, R. C., Speidel, B. A., Joseph‐Mathurin, N., Vlassenko, A. G., Gordon, B. A., Koeppe, R. A., Klunk, W. E., et al. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.12.008 · Cited by 138
Self-citationUtilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies
Su, Y., Flores, S., Hornbeck, R. C., Speidel, B., Vlassenko, A. G., Gordon, B. A., Koeppe, R. A., Klunk, W. E., Xiong, C., Morris, J. C., et al. (2018) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.04.022 · Cited by 126
Self-citationTau‐PET uptake: Regional variation in average SUVR and impact of amyloid deposition
Vemuri, P., Lowe, V. J., Knopman, D. S., Senjem, M. L., Kemp, B. J., Schwarz, C. G., Przybelski, S. A., Machulda, M. M., Petersen, R. C., & Jack, C. R. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.12.010 · Cited by 120
Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease
Vlassenko, A. G., Gordon, B. A., Goyal, M. S., Su, Y., Blazey, T. M., Durbin, T. J., Couture, L. E., Christensen, J. J., Jafri, H., Morris, J. C., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.014 · Cited by 107
Self-citationImaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease
Vlassenko, A. G., McCue, L., Jasielec, M. S., Su, Y., Gordon, B. A., Xiong, C., Holtzman, D. M., Benzinger, T. L. S., Morris, J. C., & Fagan, A. M. (2016) · Annals of Neurology · doi:10.1002/ana.24719 · Cited by 106
Self-citationGordon, B. A., Blazey, T., Su, Y., Fagan, A. M., Holtzman, D. M., Morris, J. C., & Benzinger, T. L. S. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2642 · Cited by 105
Self-citationBabulal, G. M., Roe, C. M., Stout, S. H., Rajasekar, G., Wisch, J. K., Benzinger, T. L. S., Morris, J. C., & Ances, B. M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191078 · Cited by 108
Self-citationVos, S. J. B., Gordon, B. A., Su, Y., Visser, P. J., Holtzman, D. M., Morris, J. C., Fagan, A. M., & Benzinger, T. L. S. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.025 · Cited by 98
Self-citationLoss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions
Strain, J. F., Smith, R. X., Beaumont, H., Roe, C. M., Gordon, B. A., Mishra, S., Adeyemo, B., Christensen, J. J., Su, Y., Morris, J. C., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005864 · Cited by 97
Self-citationConsiderations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease
Leuzy, A., Bollack, A., Pellegrino, D., Teunissen, C. E., Joie, R. L., Rabinovici, G. D., Franzmeier, N., Johnson, K. A., Barkhof, F., Shaw, L. M. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14528 · Cited by 109
Self-citationPredicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET
Schindler, S. E., Li, Y., Buckles, V. D., Gordon, B. A., Benzinger, T. L. S., Wang, G., Coble, D., Klunk, W. E., Fagan, A. M., Holtzman, D. M., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012775 · Cited by 89
Self-citationTiming of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset
Li, Y., Yen, D., Hendrix, R. D., Gordon, B. A., Dlamini, S. L., Barthélemy, N. R., Aschenbrenner, A. J., Henson, R. L., Herries, E. M., Volluz, K., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26891 · Cited by 90
Self-citationA Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR
Schwarz, C. G., Gunter, J. L., Lowe, V. J., Weigand, S. D., Vemuri, P., Senjem, M. L., Petersen, R. C., Knopman, D. S., & Jack, C. R. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180749 · Cited by 85
Schwarz, C. G., Senjem, M. L., Gunter, J. L., Tosakulwong, N., Weigand, S. D., Kemp, B. J., Spychalla, A. J., Vemuri, P., Petersen, R. C., Lowe, V. J., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.08.056 · Cited by 83
Chatterjee, P., Vermunt, L., Gordon, B. A., Pedrini, S., Boonkamp, L., Armstrong, N. J., Xiong, C., Singh, A. K., Li, Y., Sohrabi, H. R., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12879 · Cited by 91
Self-citationConcordance of Lumipulse cerebrospinal fluid t‐tau/Aβ42 ratio with amyloid PET status
Kaplow, J., Vandijck, M., Gray, J., Kanekiyo, M., Huyck, E., Traynham, C. J., Esquivel, R., Fagan, A. M., & Luthman, J. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12000 · Cited by 81
Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging
Wennberg, A. M. V., Gustafson, D., Hagen, C. E., Roberts, R. O., Knopman, D. S., Jack, C. R., Petersen, R. C., & Mielke, M. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151201 · Cited by 76
Lim, Y. Y., Hassenstab, J., Cruchaga, C., Goate, A., Fagan, A. M., Benzinger, T. L. S., Maruff, P., Snyder, P. J., Masters, C. L., Allegri, R., et al. (2016) · Brain · doi:10.1093/brain/aww200 · Cited by 76
Self-citationChhatwal, J. P., Schultz, S. A., McDade, E., Schultz, A. P., Liu, L., Hanseeuw, B. J., Joseph‐Mathurin, N., Feldman, R. L., Fitzpatrick, C. D., Sparks, K. P., et al. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00375-6 · Cited by 76
Self-citationBrain aerobic glycolysis and resilience in Alzheimer disease
Goyal, M. S., Blazey, T., Metcalf, N. V., McAvoy, M. P., Strain, J. F., Rahmani, M., Durbin, T. J., Xiong, C., Benzinger, T. L. S., Morris, J. C., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2212256120 · Cited by 75
Self-citationMorris, J. C., Weiner, M., Xiong, C., Beckett, L., Coble, D., Saito, N., Aisen, P. S., Allegri, R., Benzinger, T. L. S., Berman, S. B., et al. (2022) · Brain · doi:10.1093/brain/awac181 · Cited by 68
Self-citationSocioeconomic Status Mediates Racial Differences Seen Using the AT(N) Framework
Meeker, K. L., Wisch, J. K., Hudson, D., Coble, D. W., Xiong, C., Babulal, G. M., Gordon, B. A., Schindler, S. E., Cruchaga, C., Flores, S. E., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25948 · Cited by 70
Self-citationRullmann, M., Dukart, J., Hoffmann, K., Luthardt, J., Tiepolt, S., Patt, M., Gertz, H., Schroeter, M. L., Seibyl, J. P., Schulz‐Schaeffer, W., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.161893 · Cited by 66
Chiao, P., Bedell, B. J., Avants, B., Zijdenbos, A. P., Grand’Maison, M., O’Neill, P., O'Gorman, J. T., Chen, T., & Koeppe, R. A. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.209130 · Cited by 68
Widespread distribution of tauopathy in preclinical Alzheimer's disease
Schultz, S. A., Gordon, B. A., Mishra, S., Su, Y., Perrin, R. J., Cairns, N. J., Morris, J. C., Ances, B. M., & Benzinger, T. L. S. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.022 · Cited by 65
Self-citationBrown, B. M., Sohrabi, H. R., Taddei, K., Gardener, S. L., Rainey‐Smith, S. R., Peiffer, J. J., Xiong, C., Fagan, A. M., Benzinger, T. L. S., Buckles, V., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.03.008 · Cited by 65
Self-citationBateman, R. J., Li, Y., McDade, E., Llibre‐Guerra, J. J., Clifford, D. B., Atri, A., Mills, S. L., Santacruz, A. M., Wang, G., Supnet, C. B., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00024-9 · Cited by 71
Self-citationCerebral Amyloid Deposition Is Associated with Gait Parameters in the Mayo Clinic Study of Aging
Wennberg, A. M. V., Savica, R., Hagen, C. E., Roberts, R. O., Knopman, D. S., Hollman, J. H., Vemuri, P., Jack, C. R., Petersen, R. C., & Mielke, M. M. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14670 · Cited by 60
Koenig, L. N., Day, G. S., Salter, A. R., Keefe, S., Marple, L. M., Long, J. M., LaMontagne, P., Massoumzadeh, P., Snider, B. J., Kanthamneni, M., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102248 · Cited by 62
Self-citationInitiative, A. D. N., Teipel, S. J., & Grothe, M. J. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3222-3 · Cited by 57
Sturchio, A., (DIAN), T. D. I. A. C., Dwivedi, A. K., Malm, T., Wood, M. J. A., Cilia, R., Sharma, J. S., Hill, E. J., Schneider, L. S., Graff-Radford, N. R., et al. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220808 · Cited by 57
Zou, J., Tao, S., Johnson, A. S., Tomljanovic, Z., Polly, K., Klein, J., Razlighi, Q. R., Brickman, A. M., Lee, S., Stern, Y., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.09.019 · Cited by 55
Self-citationSchultz, S. A., Strain, J. F., Adedokun, A., Wang, Q., Preische, O., Kühle, J., Flores, S. E., Keefe, S., Dincer, A., Ances, B. M., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104960 · Cited by 58
Self-citationSu, Y., Blazey, T. M., Owen, C. J., Christensen, J. J., Friedrichsen, K., Joseph-Mathurin, N., Wang, Q., Hornbeck, R. C., Ances, B. M., Snyder, A. Z., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152082 · Cited by 56
Self-citationBinette, A. P., Theaud, G., Rheault, F., Roy, M., Collins, D. L., Levin, J., Mori, H., Lee, J. H., Farlow, M. R., Schofield, P. R., et al. (2021) · eLife · doi:10.7554/elife.62929 · Cited by 60
Self-citationWisch, J. K., Meeker, K. L., Gordon, B. A., Flores, S. E., Dincer, A., Grant, E., Benzinger, T. L. S., Morris, J. C., & Ances, B. M. (2020) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000393 · Cited by 56
Self-citationCerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage
Meeker, K. L., Butt, O. H., Gordon, B. A., Fagan, A. M., Schindler, S. E., Morris, J. C., Benzinger, T. L. S., & Ances, B. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105662 · Cited by 54
Self-citationLongitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study
Xiong, C., Jasielec, M. S., Weng, H., Fagan, A. M., Benzinger, T. L. S., Head, D., Hassenstab, J., Grant, E., Sutphen, C. L., Buckles, V., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002593 · Cited by 54
Self-citationBussy, A., Snider, B. J., Coble, D. W., Xiong, C., Fagan, A. M., Cruchaga, C., Benzinger, T. L. S., Gordon, B. A., Hassenstab, J. J., Bateman, R. J., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.10.011 · Cited by 57
Self-citationUpward drift in cerebrospinal fluid amyloid β 42 assay values for more than 10 years
Schindler, S. E., Sutphen, C. L., Teunissen, C. E., McCue, L. M., Morris, J. C., Holtzman, D. M., Mulder, S. D., Scheltens, P., Xiong, C., & Fagan, A. M. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.06.2264 · Cited by 48
Self-citationLong, J. M., Coble, D. W., Xiong, C., Schindler, S. E., Perrin, R. J., Gordon, B. A., Benzinger, T. L. S., Grant, E., Fagan, A. M., Harari, O., et al. (2022) · Brain · doi:10.1093/brain/awac250 · Cited by 49
Self-citationJoseph‐Mathurin, N., Llibre‐Guerra, J. J., Li, Y., McCullough, A. A., Hofmann, C., Wojtowicz, J., Park, E., Wang, G., Preboske, G. M., Wáng, Q., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26511 · Cited by 48
Self-citationYang, J., Hu, C., Guo, N., Dutta, J., Vaina, L. M., Johnson, K. A., Sepulcre, J., Fakhri, G. E., & Li, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-13339-7 · Cited by 50
Self-citationMR Imaging–Guided Partial Volume Correction of PET Data in PET/MR Imaging
Erlandsson, K., Dickson, J. C., Arridge, S., Atkinson, D., Sebastien Ourselin, A., & Hutton, B. F. (2015) · PET Clinics · doi:10.1016/j.cpet.2015.09.002 · Cited by 45
Technical and instrumentational foundations of PET/MRI
Rausch, I., Quick, H. H., Cal-González, J., Sattler, B., Boellaard, R., & Beyer, T. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.04.004 · Cited by 47
McKay, N. S., Gordon, B. A., Hornbeck, R. C., Dincer, A., Flores, S. E., Keefe, S., Joseph‐Mathurin, N., Jack, C. R., Koeppe, R. A., Millar, P. R., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01359-8 · Cited by 44
Self-citationShidahara, M., Thomas, B. A., Okamura, N., Ibaraki, M., Matsubara, K., Oyama, S., Ishikawa, Y., Watanuki, S., Iwata, R., Furumoto, S., et al. (2017) · Annals of Nuclear Medicine · doi:10.1007/s12149-017-1185-0 · Cited by 43
MRI-Driven PET Image Optimization for Neurological Applications
Zhu, Y., & Zhu, X. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00782 · Cited by 42
Lu, J., Bao, W., Li, M., Li, L., Zhang, Z., Alberts, I., Brendel, M., Cumming, P. D., Lu, H., Xiao, Z., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00604 · Cited by 41
Wang, Q., Chen, G., Schindler, S. E., Christensen, J. J., McKay, N. S., Liu, J., Wang, S., Sun, Z., Hassenstab, J. J., Su, Y., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001152 · Cited by 46
Self-citationWisch, J. K., McKay, N. S., Boerwinkle, A. H., Kennedy, J., Flores, S., Handen, B. L., Christian, B. T., Head, E., Mapstone, M., Rafii, M. S., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00084-x · Cited by 37
Self-citationMecca, A. P., Barcelos, N. M., Wang, S., Brück, A., Nabulsi, N., Planeta‐Wilson, B., Nadelmann, J. B., Benincasa, A. L., Ropchan, J. R., Huang, Y. H., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.027 · Cited by 40
Thirunavu, V. M., McCullough, A. A., Su, Y., Flores, S. E., Dincer, A., Morris, J. C., Cruchaga, C., Benzinger, T. L. S., & Gordon, B. A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190154 · Cited by 37
Self-citationLim, Y. Y., Maruff, P. T., Barthélemy, N. R., Goate, A., Hassenstab, J. J., Sato, C., Fagan, A. M., Benzinger, T. L. S., Xiong, C., Cruchaga, C., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2021.5181 · Cited by 34
Self-citationHofmann, A., Häsler, L. M., Lambert, M., Kaeser, S. A., Gräber‐Sultan, S., Obermüller, U., Kuder-Buletta, E., la Fougère, C., Laske, C., Vöglein, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52937-8 · Cited by 45
Self-citationTudorascu, D., Minhas, D. S., Lao, P. J., Betthauser, T. J., Yu, Z., Laymon, C. M., Lopresti, B. J., Mathis, C. A., Klunk, W. E., Handen, B. L., et al. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.03.006 · Cited by 35
Self-citationZhao, Q., Liu, M., Ha, L., Zhou, Y., & Initiative, A. D. N. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00486 · Cited by 39
APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression
Dincer, A., Chen, C. D., McKay, N. S., Koenig, L. N., McCullough, A. A., Flores, S. E., Keefe, S., Schultz, S. A., Feldman, R. L., Joseph‐Mathurin, N., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl7646 · Cited by 34
Self-citationCerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease
Wang, F., Gordon, B. A., Ryman, D. C., Ma, S., Xiong, C., Hassenstab, J. J., Goate, A., Fagan, A. M., Cairns, N. J., Marcus, D. S., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001903 · Cited by 34
Self-citationSchwarz, C. G., Jones, D. T., Gunter, J. L., Lowe, V. J., Vemuri, P., Senjem, M. L., Petersen, R. C., Knopman, D. S., Jack, C. R., & Initiative, T. A. D. N. (2017) · Human Brain Mapping · doi:10.1002/hbm.23622 · Cited by 34
Predicting dysfunctional age-related task activations from resting-state network alterations
Mill, R. D., Gordon, B. A., Balota, D. A., Zacks, J. M., & Cole, M. W. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117167 · Cited by 32
Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease
Dincer, A., Gordon, B. A., Hari‐Raj, A., Keefe, S., Flores, S. E., McKay, N. S., Paulick, A. M., Shady, K., Feldman, R. L., Hornbeck, R. C., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102491 · Cited by 36
Self-citationMatsubara, K., Ibaraki, M., Shimada, H., Ikoma, Y., Suhara, T., Kinoshita, T., & Itco, H. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.09.028 · Cited by 33
PET Image Deblurring and Super-Resolution With an MR-Based Joint Entropy Prior
Song, T.-A., Yang, F., Chowdhury, S. R., Kim, K., Johnson, K. A., Fakhri, G. E., Li, Q., & Dutta, J. (2019) · IEEE Transactions on Computational Imaging · doi:10.1109/tci.2019.2913287 · Cited by 33
Self-citationSakr, F. A., Grothe, M. J., Cavedo, E., Jelistratova, I., Habert, M., Dyrba, M., González‐Escamilla, G., Bertin, H., Locatelli, M., Lehéricy, S., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0466-3 · Cited by 32
Effect ofBDNFVal66Met on disease markers in dominantly inherited Alzheimer's disease
Lim, Y. Y., Hassenstab, J. J., Goate, A., Fagan, A. M., Benzinger, T. L. S., Cruchaga, C., McDade, E., Chhatwal, J. P., Levin, J., Farlow, M. R., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25299 · Cited by 31
Self-citationDavis, J. D., Babulal, G. M., Papandonatos, G. D., Burke, E. M., Rosnick, C. B., Ott, B. R., & Roe, C. M. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.596257 · Cited by 31
Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40
Wisch, J. K., Gordon, B. A., Boerwinkle, A. H., Luckett, P. H., Bollinger, J. G., Ovod, V., Li, Y., Henson, R. L., West, T., Meyer, M. R., et al. (2023) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12405 · Cited by 35
Self-citationAlzheimer Disease Pathology and Neurodegeneration in Midlife Obesity: A Pilot Study
Dolatshahi, M., Commean, P. K., Rahmani, F., Liu, J., Lloyd, L., Nguyen, C., Hantler, N., Ly, M. J., Yu, G. Z., Ippolito, J. E., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0707 · Cited by 31
Self-citationVascular endothelial‐cadherin as a marker of endothelial injury in preclinical Alzheimer disease
Tarawneh, R. M., Kasper, R. S., Sanford, J., Phuah, C., Hassenstab, J. J., & Cruchaga, C. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51685 · Cited by 29
Metadata
- Authors
- Su, Y., Blazey, T. M., Snyder, A. Z., Raichle, M. E., Marcus, D. S., Ances, B. M., Bateman, R. J., Cairns, N. J., Aldea, P., Cash, L., Christensen, J. J., Friedrichsen, K., Hornbeck, R. C., Farrar, A. M., Owen, C. J., Mayeux, R., Brickman, A. M., Klunk, W., Price, J. C., Thompson, P. M., Ghetti, B., Saykin, A. J., Sperling, R. A., Johnson, K. A., Schofield, P. R., Buckles, V., Morris, J. C., & Benzinger, T. L. S.
- Affiliations
- Washington University in St. Louis (US)
- Columbia University Irving Medical Center (US)
- University of Pittsburgh (US)
- University of Southern California (US)
- Indiana University School of Medicine (US)
- Indiana University Indianapolis (US)
- Harvard University (US)
- UNSW Sydney (AU)
- Corresponding author
- Su, Yi
- ORCID
- Su, Yi
- Blazey, Tyler M.
- Snyder, Abraham Z.
- Raichle, Marcus E.
- Marcus, Daniel S.
- Ances, Beau M.
- Bateman, Randall J.
- Cairns, Nigel J.
- Friedrichsen, Karl
- Hornbeck, Russ C.
- Mayeux, Richard
- Brickman, Adam M.
- Klunk, William
- Price, Julie C.
- Thompson, Paul M.
- Saykin, Andrew J.
- Sperling, Reisa A.
- Johnson, Keith A.
- Schofield, Peter R.
- Morris, John C.
- Benzinger, Tammie L.S.
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 107
- Pages
- 55-64
- ISSN
- 1053-8119 (ISSN-L)
- PMC
- PMC4300252
- OpenAlex
- W1977541817
- Semantic Scholar
- 77ada80d1d7d2ece501b4ca861e835ea5129a4f1
- Cited by
- 247
- References
- 49
- Citations by year
- 2026: 16 · 2025: 21 · 2024: 21 · 2023: 26 · 2022: 34 · 2021: 22 · 2020: 27 · 2019: 14 · 2018: 24 · 2017: 11 · 2016: 22 · 2015: 8
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- NeuroImage (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- Knight Alzheimer's Disease Research Center (P50AG005681, P01AG003991, P01AG026276, U19AG032438, P30NS048056)
- Charles F. and Joanne Knight Alzheimer's Initiative
- David and Betty Farrell Medical Research Fund
- F Simmons
- O Mohan
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- partial volume correction, amyloid imaging, Pittsburgh compound B, PET, amyloid deposition, image registration, image segmentation, dementing disorders
- MeSH terms
- Algorithms, Alzheimer Disease, Amyloid, Aniline Compounds, Cerebral Cortex, Computer Simulation, Cross-Sectional Studies, Humans, Individuality, Longitudinal Studies, Thiazoles, Reproducibility of Results, Cohort Studies, Amyloid Neuropathies, Radiopharmaceuticals, Positron-Emission Tomography, Benzothiazoles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
